Jessica S Citronberg1,2, Lynne R Wilkens3, Loic Le Marchand3, Unhee Lim3, Kristine R Monroe4, Meredith A J Hullar5, Emily White6,5, Polly A Newcomb6,5, Johanna W Lampe6,5. 1. Department of Epidemiology, University of Washington, Seattle, WA, USA. jcitronb@fredhutch.org. 2. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, M4-B402, PO Box 19024, Seattle, WA, USA. jcitronb@fredhutch.org. 3. Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. 4. Keck School of Medicine of University of Southern California, Los Angeles, CA, USA. 5. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, M4-B402, PO Box 19024, Seattle, WA, USA. 6. Department of Epidemiology, University of Washington, Seattle, WA, USA.
Abstract
BACKGROUND: Lipopolysaccharide (LPS), an endotoxin found on the outer cell wall of Gram-negative bacteria, increases inflammatory response signaling and may play a role in the pathogenesis of several adverse outcomes, including inflammatory bowel diseases, cardiovascular disease, and cancer. While LPS is hypothesized to be associated with colorectal carcinogenesis, there are relatively few human studies which have examined this association. METHODS: We examined the association between colorectal cancer (CRC) and plasma lipopolysaccharide-binding protein (LBP), a marker of LPS, in 1,638 participants (819 CRC cases and 819 controls) matched on multiple factors, including age, sex, and race/ethnicity, from the Multiethnic Cohort study. Conditional logistic regression models were used to estimate the multivariable-adjusted odds ratios (OR) and 95% confidence intervals (95% CI). RESULTS: Compared to individuals whose LBP concentrations were in the lowest quartile, the ORs associated with second, third, and fourth quartiles were 1.23 (95% CI 0.91-1.67), 1.36 (95% CI 1.01-1.83), and 1.01 (95% CI 0.73-1.39), respectively, (p trend = 0.66). No differences were observed by BMI, fiber intake, saturated fat intake, cancer site, or cancer stage. CONCLUSIONS: This study did not find an overall statistically significant association between LBP (as a marker of LPS exposure) and CRC. Further prospective studies with multiple LBP measurements are needed to validate current findings.
BACKGROUND:Lipopolysaccharide (LPS), an endotoxin found on the outer cell wall of Gram-negative bacteria, increases inflammatory response signaling and may play a role in the pathogenesis of several adverse outcomes, including inflammatory bowel diseases, cardiovascular disease, and cancer. While LPS is hypothesized to be associated with colorectal carcinogenesis, there are relatively few human studies which have examined this association. METHODS: We examined the association between colorectal cancer (CRC) and plasma lipopolysaccharide-binding protein (LBP), a marker of LPS, in 1,638 participants (819 CRC cases and 819 controls) matched on multiple factors, including age, sex, and race/ethnicity, from the Multiethnic Cohort study. Conditional logistic regression models were used to estimate the multivariable-adjusted odds ratios (OR) and 95% confidence intervals (95% CI). RESULTS: Compared to individuals whose LBP concentrations were in the lowest quartile, the ORs associated with second, third, and fourth quartiles were 1.23 (95% CI 0.91-1.67), 1.36 (95% CI 1.01-1.83), and 1.01 (95% CI 0.73-1.39), respectively, (p trend = 0.66). No differences were observed by BMI, fiber intake, saturated fat intake, cancer site, or cancer stage. CONCLUSIONS: This study did not find an overall statistically significant association between LBP (as a marker of LPS exposure) and CRC. Further prospective studies with multiple LBP measurements are needed to validate current findings.
Entities:
Keywords:
Colorectal cancer; Multiethnic population; lipopolysaccharide-binding protein
Authors: Jacques Amar; Rémy Burcelin; Jean Bernard Ruidavets; Patrice D Cani; Josette Fauvel; Marie Christine Alessi; Bernard Chamontin; Jean Ferriéres Journal: Am J Clin Nutr Date: 2008-05 Impact factor: 7.045
Authors: Philipp M Lepper; Christian Schumann; Kathy Triantafilou; F Maximilian Rasche; Tibor Schuster; Hedwig Frank; E Marion Schneider; Martha Triantafilou; Maximilian von Eynatten Journal: J Am Coll Cardiol Date: 2007-06-18 Impact factor: 24.094
Authors: Husam Ghanim; Sanaa Abuaysheh; Ching Ling Sia; Kelly Korzeniewski; Ajay Chaudhuri; Jose Manuel Fernandez-Real; Paresh Dandona Journal: Diabetes Care Date: 2009-09-15 Impact factor: 17.152
Authors: Chloe P Lozano; Lynne R Wilkens; Yurii B Shvetsov; Gertraud Maskarinec; Song-Yi Park; John A Shepherd; Carol J Boushey; James R Hebert; Michael D Wirth; Thomas Ernst; Timothy Randolph; Unhee Lim; Johanna W Lampe; Loïc Le Marchand; Meredith A J Hullar Journal: Am J Clin Nutr Date: 2022-05-01 Impact factor: 8.472